journal articleLitStream CollectionStatin therapy associated with 9% increase in diabetes risk2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00001pmid: N/A
journal articleLitStream CollectionProducts containing nimesulide are currently undergoing a full assessment by the EMA's CHMP,2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00004pmid: N/A
journal articleLitStream CollectionRosiglitazone: accusations over cardiovascular safety2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00002pmid: N/A
journal articleLitStream CollectionThe European Medicines Agency is recommending that becaplermin [Regranex] be contraindicated in patients with any pre-existing cancer,2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00003pmid: N/A
journal articleLitStream CollectionFDA requires new strategy to ensure safe use of LABAs2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00006pmid: N/A
journal articleLitStream CollectionAccutane label warns of severe skin reactions2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00005pmid: N/A
journal articleLitStream CollectionBiogen Idec and Elan have announced four new cases of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri (natalizumab),2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00007pmid: N/A
journal articleLitStream CollectionGSK responds to proposed LABA label revisions2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00008pmid: N/A
journal articleLitStream CollectionMaalox mix-up causes confusion2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00010pmid: N/A
journal articleLitStream CollectionNovartis Oncology have issued a letter alerting healthcare providers of new safety information, including a boxed warning, for Exjade2013 Reactions Weeklydoi: 10.2165/00128415-201012900-00009pmid: N/A